Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B
- PMID: 25717246
- PMCID: PMC4326148
- DOI: 10.3748/wjg.v21.i7.2116
Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B
Abstract
Aim: To investigate the predictors of proximal kidney tubular dysfunction (PKTD) induced by adefovir dipivoxil (ADV) treatment for chronic hepatitis B.
Methods: Seventy-nine patients (age at the evaluation of PKTD: 56.9±10.7 years) with chronic hepatitis B undergoing long-term oral antiviral nucleos(t)ide analogue treatment were consecutively recruited. PKTD was defined by the presence of at least two of the following five abnormalities: phosphate diabetes, nondiabetic glucosuria, metabolic acidosis, β2-microglobulinuria, or renal hypouricemia. The single-nucleotide polymorphisms (SNPs) in the SLC22A6 gene encoding human organic anion transporter 1 (hOAT1) and ABCC2 encoding multidrug resistance protein 2 (MRP2) were analyzed using the TaqMan Allelic Discrimination Demonstration Kit.
Results: Nine (30.0%) of the 30 ADV-treated patients were diagnosed with PKTD, while no patients without ADV developed PKTD (P<0.001). Three patients with ADV were diagnosed with symptomatic osteomalacia. Among the patients who took ADV, those with PKTD were of higher age at initiation, had significantly longer treatment duration, and had a significantly lower body mass index than those without PKTD. The incidence of PKTD dramatically increased after 96 mo from the start of ADV administration. In contrast, the SNPs were not correlated with PKTD. Logistic regression analysis extracted older age at initiation (OR=5.0, 95%CI: 1.1-23.4; P=0.040) and longer treatment duration (OR=3.2, 95%CI: 1.2-8.6; P=0.020) as significant factors associated with PKTD.
Conclusion: Our results suggest that the tubular function of the kidney of older patients undergoing long-term ADV treatment should be carefully evaluated.
Keywords: Adefovir dipivoxil; Fanconi syndrome; Hepatitis B virus; Proximal kidney tubular dysfunction.
Figures
Similar articles
-
Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.BMC Pharmacol Toxicol. 2018 May 16;19(1):23. doi: 10.1186/s40360-018-0212-7. BMC Pharmacol Toxicol. 2018. PMID: 29769119 Free PMC article.
-
Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors.Bone. 2016 Dec;93:97-103. doi: 10.1016/j.bone.2016.09.017. Epub 2016 Sep 21. Bone. 2016. PMID: 27664568
-
Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B.World J Gastroenterol. 2015 Mar 28;21(12):3657-62. doi: 10.3748/wjg.v21.i12.3657. World J Gastroenterol. 2015. PMID: 25834334 Free PMC article.
-
Drug safety evaluation of adefovir in HBV infection.Expert Opin Drug Saf. 2011 Sep;10(5):809-18. doi: 10.1517/14740338.2011.593507. Epub 2011 Jun 15. Expert Opin Drug Saf. 2011. PMID: 21671843 Review.
-
Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B.Intern Med. 2014;53(3):233-7. doi: 10.2169/internalmedicine.53.1213. Intern Med. 2014. PMID: 24492692 Review.
Cited by
-
Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?Drug Des Devel Ther. 2019 Apr 10;13:1127-1133. doi: 10.2147/DDDT.S192632. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31118563 Free PMC article.
-
Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.BMC Pharmacol Toxicol. 2018 May 16;19(1):23. doi: 10.1186/s40360-018-0212-7. BMC Pharmacol Toxicol. 2018. PMID: 29769119 Free PMC article.
-
Nucleotide Analogue-Related Proximal Renal Tubular Dysfunction during Long-Term Treatment of Chronic Hepatitis B: A Cross-Sectional Study.Gastroenterol Res Pract. 2016;2016:2952635. doi: 10.1155/2016/2952635. Epub 2016 Oct 31. Gastroenterol Res Pract. 2016. PMID: 27872640 Free PMC article.
-
Adefovir dipivoxil-associated Fanconi syndrome combined with peripheral neuropathy: a case report and literature review.Front Pharmacol. 2025 Aug 1;16:1585126. doi: 10.3389/fphar.2025.1585126. eCollection 2025. Front Pharmacol. 2025. PMID: 40822478 Free PMC article.
-
Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B.Biomed Res Int. 2017;2017:4327385. doi: 10.1155/2017/4327385. Epub 2017 Oct 29. Biomed Res Int. 2017. PMID: 29214169 Free PMC article.
References
-
- Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373:582–592. - PubMed
-
- Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107. - PubMed
-
- Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kusaba T, Shingu T, Hayashida K, Kaji M. An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol. 1983;118:787–794. - PubMed
-
- Furusyo N, Hayashi J, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period. Am J Trop Med Hyg. 1998;59:693–698. - PubMed
-
- Liaw YF. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy. Antivir Ther. 2006;11:669–679. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases